Crossmark

Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma

Published Online: 2016-05-09

Published Print: 2016-09

Authors

Desai, A V

Heneghan, M B

Li, Y

Bunin, N J

Grupp, S A

Bagatell, R

Seif, A E
License Information

Text and Data Mining valid from 2016-05-09

Version of Record valid from 2016-05-09
More Information

Article History

Received: 18 August 2015

Revised: 9 February 2016

Accepted: 28 February 2016

First Online: 9 May 2016

Competing interests

: The authors declare no conflict of interest.

Document is current